Tag: AMB-FUBINACA

Synthetic drugs

Name that Drug: A stimulating psychoactive perspective

September 15, 2015 By

DATIA focus features a regular column titled, “Name that Drug” where interesting facts about a mystery drug are described.

Synthetic drugs

Synthetic drugs: Common questions

July 24, 2015 By

Dr. Kim Samano presented information about synthetic cannabinoids ("K2/Spice") and designer stimulants known as “bath salts” in our recent webinar.

Synthetic drugs

Synthetic drugs: What you need to know

June 22, 2015 By

Our webinar will provide an overview of synthetic drugs, review trends in usage and patterns and discuss the challenges for a workplace program.

Synthetic drugs

CNN reports on synthetic drugs

December 16, 2014 By

Media reports tragic accounts of taking synthetic drugs. Quest Diagnostics monitors these ever-changing substances to add to our drug test panels.

Synthetic drugs

Dangers of synthetic cannabinoids

November 3, 2014 By

Synthetic cannabinoids change frequently and Quest works to stay current with drug-use patterns by adding compounds to our drug test panels.

Synthetic drugs

New to drug testing: Synthetic marijuana

November 6, 2013 By

In our ongoing quest to help keep workplaces drug-free, we now offer a synthetic cannabinoids panel to test for commonly detected compounds.

Synthetic drugs

Quest Diagnostics tests for synthetic cannabinoids

November 4, 2013 By

Quest Diagnostics now offers a synthetic cannabinoids panel testing for AM-2201, JWH-018, JWH-019, JWH-073, JWH-250, UR-144 and XLR11 compounds.

Synthetic drugs

Quest Diagnostics now tests for synthetic stimulants (bath salts)

August 19, 2013 By

Quest Diagnostics offers a comprehensive suite of drug testing products and services which now includes testing for synthetic stimulants (bath salts).

Synthetic drugs

Synthetic cannabinoid user profile

May 21, 2013 By

The first study to obtain a detailed profile of users of synthetic cannabinoid was published in the May 20 issue of the CESAR report.

News

Synthetic cannabinoids linked to acute kidney injury

February 19, 2013 By

Acute kidney injury following exposure to synthetic cannabinoids, in sixteen cases, has been identified in six states.